Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)
This study is currently recruiting participants.
Verified August 2012 by AIO-Studien-gGmbH
Sponsor:
AIO-Studien-gGmbH
Collaborator:
Fresenius Biotech GmbH
Information provided by (Responsible Party):
AIO-Studien-gGmbH
ClinicalTrials.gov Identifier:
NCT01504256
First received: January 3, 2012
Last updated: August 16, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | April 2013 (Final data collection date for primary outcome measure) |